We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Specialized Stain Enables Exceptional Bone Marrow Diagnostic Pathology

By LabMedica International staff writers
Posted on 13 Mar 2014
Print article
Caption: Bone marrow stained with Dako's Jenner-Wright Giemsa: nuclei – blue; eosinophils – bright pink; lymphocytes – shades of pink, gray, or blue depending on cell type and development (Photo courtesy of Dako).
Caption: Bone marrow stained with Dako's Jenner-Wright Giemsa: nuclei – blue; eosinophils – bright pink; lymphocytes – shades of pink, gray, or blue depending on cell type and development (Photo courtesy of Dako).
A new tissue stain has been specially developed to provide superior clarity of differentiation and detail in bone marrow tissue samples for disease diagnosis.

Dako (Glostrup, Denmark), an Agilent Technologies (Santa Clara, CA, USA) company, has now added its new Jenner-Wright Giemsa stain to Dako's broad palette of automated stains – its Artisan Link portfolio. Dako is releasing the stain in its continuing mission to provide pathology labs with the most advanced special stain solutions and the broadest portfolio.

The Jenner-Wright Giemsa stain is designed to give pathologists an added dimension to the visualization of the cell morphology by providing clear differentiation and detail of hematopoietic cells in bone marrow samples for the diagnosis of diseases, such as cancer, aplastic anemia, and myelofibrosis.

The Artisan portfolio provides the broadest range of automated special stains available—currently consisting of 31 high-quality stains, covering most of a typical laboratory’s special stain needs. Dako also plans to add more stains to the portfolio.

The portfolio also enables labs to take advantage of the productivity benefits possible through automation with the Artisan Link Pro instrument. Laboratories that routinely do special stains will benefit from a 64% reduction in hands-on time with Artisan Link Pro, compared with the same protocols performed manually. Significant gains in lab safety can be realized because the Artisan Link Pro and its ready-to-use reagents are closed, minimizing exposure to hazardous chemicals, and can be connected to ventilation systems. The instrument also features a unique waste separation system that reduces hazardous waste generation, helping labs minimize disposal and associated costs.

"Dako’s Jenner-Wright Giemsa special stain for bone marrow is excellent, and allows us, for the first time, to automate the diagnosis of various diseases using bone marrow tissue," said Prof. Hermann Herbst, director of the Vivantes Pathology Department in Berlin. "Artisan Link Pro stains are fabulous to look at. This stain in particular offers an unprecedented ability to use bone marrow and provides exceptionally clear differentiation and detail."

Related Links:

Dako
Dako's Jenner-Wright Giemsa kit
Agilent Technologies 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.